Duchesnay Flagged for Omitting Risks of Morning Sickness Drug

Washington Drug Letter
A A
Shortly after Duchesnay received FDA approval for its morning sickness drug Diclegis, the agency says the Canadian drugmaker sent a letter to customers touting the drug’s benefits but none of its risks.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00